Trial for newly treated obsessive-compulsive disorder
Treatments studied
Part of Mental health clinical trials.
This phase 2 study tests an OCD treatment strategy for people who have not yet had OCD medications or recent OCD therapy. It aims to reduce OCD symptoms, especially for those with moderate-to-severe symptom levels.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a main diagnosis of obsessive-compulsive disorder (OCD) based on DSM-5 criteria
- You are between 18 and 65 years old
- Your OCD symptoms are at least moderate (Yale-Brown OCD Scale score of 20 or higher)
- You have not taken OCD medications before, and you have not had OCD psychotherapy in the last month
- You can provide written informed consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if valbenazine, a medication that affects brain chemicals, can reduce OCD symptoms in adults. Participants must have moderate to severe OCD and take the pill daily for the study period.
This study follows people with obsessive-compulsive disorder (OCD) over time to better understand how the condition progresses and how people respond to different treatments. By joining, you help researchers learn more about OCD, which could improve future care for others.
This study looks at how brain networks change before and after starting fluoxetine (an SSRI antidepressant) in people with obsessive-compulsive disorder (OCD). It also compares these brain scan patterns with people without OCD to help predict who may respond to treatment.
This Phase 2 study tests whether psilocybin-assisted psychotherapy can reduce symptoms in adults with severe, treatment-resistant OCD. It also focuses on safety and whether this approach is practical to run.
This trial studies whether adding structured talk therapy (CBT) can help some children with obsessive-compulsive disorder (OCD) reduce and potentially stop their OCD medicine. It’s designed for kids who are still having meaningful symptoms despite being on an OCD medication long enough.
This study tests whether a drug called psilocybin (the active ingredient in 'magic mushrooms') can help people with obsessive-compulsive disorder (OCD) who haven't found relief from standard treatments. It involves a few sessions with the drug under supervision, along with MRI scans and follow-up visits.
Hear when a new Obsessive-Compulsive Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.